Hyundai Bioscience Past Earnings Performance
Past criteria checks 0/6
Hyundai Bioscience's earnings have been declining at an average annual rate of -50.3%, while the Personal Products industry saw earnings growing at 5% annually. Revenues have been declining at an average rate of 33.4% per year.
Key information
-50.3%
Earnings growth rate
-49.3%
EPS growth rate
| Personal Products Industry Growth | 3.8% |
| Revenue growth rate | -33.4% |
| Return on equity | -32.0% |
| Net Margin | -152.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About
Mar 14
Is Hyundai Bioscience (KOSDAQ:048410) Using Too Much Debt?
Feb 07
Imagine Holding Hyundai Bioscience (KOSDAQ:048410) Shares While The Price Zoomed 439% Higher
Jan 03The Trends At Hyundai Bioscience (KOSDAQ:048410) That You Should Know About
Nov 29Revenue & Expenses BreakdownBeta
How Hyundai Bioscience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 9,481 | -14,499 | 7,835 | 6,401 |
| 30 Sep 23 | 10,061 | -17,559 | 12,227 | 9,617 |
| 30 Jun 23 | 10,481 | -12,224 | 17,564 | 9,617 |
| 31 Mar 23 | 8,671 | -15,770 | 11,844 | 17,114 |
| 31 Dec 22 | 7,852 | -15,807 | 11,802 | 16,456 |
| 30 Sep 22 | 8,659 | -18,174 | 7,205 | 13,820 |
| 30 Jun 22 | 8,739 | -24,122 | 2,107 | 13,820 |
| 31 Mar 22 | 9,631 | -19,713 | 8,209 | 4,556 |
| 31 Dec 21 | 9,241 | -20,051 | 6,063 | 4,763 |
| 30 Sep 21 | 8,696 | -13,115 | 6,189 | 4,021 |
| 30 Jun 21 | 9,193 | -10,845 | 5,457 | 4,021 |
| 31 Mar 21 | 10,285 | -9,553 | 5,043 | 3,320 |
| 31 Dec 20 | 12,511 | -8,260 | 6,070 | 1,968 |
| 30 Sep 20 | 18,275 | -1,691 | 5,531 | 1,114 |
| 30 Jun 20 | 21,868 | -559 | 5,916 | 1,114 |
| 31 Mar 20 | 26,434 | -71 | 6,989 | 1,053 |
| 31 Dec 19 | 30,086 | 1,569 | 7,070 | 1,290 |
| 30 Sep 19 | 31,481 | 4,116 | 7,509 | 1,406 |
| 30 Jun 19 | 32,363 | 4,039 | 6,868 | 1,797 |
| 31 Mar 19 | 32,926 | 3,855 | 7,871 | 1,968 |
| 31 Dec 18 | 31,236 | 3,108 | 9,775 | 1,703 |
| 30 Sep 18 | 33,569 | 2,208 | 10,581 | 1,849 |
| 30 Jun 18 | 34,127 | 2,100 | 10,771 | 1,947 |
| 31 Mar 18 | 32,164 | 2,044 | 10,354 | 1,908 |
| 31 Dec 17 | 31,970 | 1,218 | 10,570 | 2,050 |
| 30 Sep 17 | 31,398 | -6,244 | 14,849 | 2,091 |
| 30 Jun 17 | 31,790 | -8,992 | 15,548 | 2,127 |
| 31 Mar 17 | 32,316 | -9,329 | 16,168 | 2,244 |
| 31 Dec 16 | 36,101 | -8,070 | 16,180 | 2,115 |
| 30 Sep 16 | 33,497 | -2,934 | 11,279 | 1,831 |
| 30 Jun 16 | 32,630 | 131 | 10,405 | 1,556 |
| 31 Mar 16 | 38,621 | 692 | 9,631 | 1,241 |
| 31 Dec 15 | 40,675 | 711 | 9,014 | 1,149 |
| 30 Sep 15 | 41,067 | 1,242 | 8,684 | 986 |
| 30 Jun 15 | 40,609 | 501 | 7,831 | 824 |
| 31 Mar 15 | 33,182 | -613 | 7,196 | 633 |
| 31 Dec 14 | 28,913 | -1,323 | 7,146 | 460 |
| 30 Sep 14 | 27,058 | -4,498 | 8,397 | 629 |
| 30 Jun 14 | 25,218 | -6,735 | 9,600 | 975 |
| 31 Mar 14 | 24,750 | -8,500 | 10,857 | 1,265 |
| 31 Dec 13 | 25,538 | -9,499 | 11,656 | 1,528 |
| 30 Sep 13 | 30,444 | -6,650 | 11,115 | 1,611 |
| 30 Jun 13 | 28,627 | -8,455 | 11,160 | 1,387 |
Quality Earnings: A048410 is currently unprofitable.
Growing Profit Margin: A048410 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A048410 is unprofitable, and losses have increased over the past 5 years at a rate of 50.3% per year.
Accelerating Growth: Unable to compare A048410's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A048410 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (38.8%).
Return on Equity
High ROE: A048410 has a negative Return on Equity (-32.03%), as it is currently unprofitable.